Company / R&D per Share
Inogen Inc R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.87
FY2025
5-year range
$0.42 / $0.94
FY2021-FY2025
Trend
-7.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.72 to $0.87 over the past 2 years.
Based on SEC 10-K filings.
0.87 in FY2025 with a 5-year CAGR of +22.3%.
Improved from $0.72 to $0.87 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +12.1%
- 5-Year CAGR
- +22.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 7.3% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.87 | -7.3% |
| FY2024 | $0.94 | +30.2% |
| FY2023 | $0.72 | +16.6% |
| FY2022 | $0.62 | +45.8% |
| FY2021 | $0.42 | +33.1% |
| FY2020 | $0.32 | +30.8% |
| FY2019 | $0.24 | +0.1% |
| FY2018 | $0.24 | +18.9% |
| FY2017 | $0.21 | +36.2% |
| FY2016 | $0.15 | +19.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026